BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 28168196)

  • 21. Body mass index and survival in patients with renal cell carcinoma: a clinical-based cohort and meta-analysis.
    Choi Y; Park B; Jeong BC; Seo SI; Jeon SS; Choi HY; Adami HO; Lee JE; Lee HM
    Int J Cancer; 2013 Feb; 132(3):625-34. PubMed ID: 22610826
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neutrophil-to-lymphocyte ratio as an independent predictor for survival in patients with localized clear cell renal cell carcinoma after radiofrequency ablation: a propensity score matching analysis.
    Chang X; Zhang F; Liu T; Wang W; Guo H
    Int Urol Nephrol; 2017 Jun; 49(6):967-974. PubMed ID: 28247169
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low predictive accuracy of the Kattan postoperative nomogram for renal cell carcinoma recurrence in a population of French patients.
    Hupertan V; Roupret M; Poisson JF; Chretien Y; Dufour B; Thiounn N; Mejean A
    Cancer; 2006 Dec; 107(11):2604-8. PubMed ID: 17075871
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of perioperative blood transfusion on oncologic outcomes in patients with nonmetastatic renal cell carcinoma treated with curative nephrectomy: A retrospective analysis of a large, single-institutional cohort.
    Seon DY; Kwak C; Kim HH; Ku JH; Kim HS
    Investig Clin Urol; 2020 Mar; 61(2):136-145. PubMed ID: 32158964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Statin Use and Serum Lipid Levels Are Associated With Survival Outcomes After Surgery for Renal Cell Carcinoma.
    Haddad AQ; Jiang L; Cadeddu JA; Lotan Y; Gahan JC; Hynan LS; Gupta N; Raj GV; Sagalowsky AI; Margulis V
    Urology; 2015 Dec; 86(6):1146-52. PubMed ID: 26416007
    [TBL] [Abstract][Full Text] [Related]  

  • 26. β1,6-N-acetylglucosaminyltransferase V predicts recurrence and survival of patients with clear-cell renal cell carcinoma after surgical resection.
    Liu Y; Liu H; Liu W; Zhang W; An H; Xu J
    World J Urol; 2015 Nov; 33(11):1791-9. PubMed ID: 25630622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic impact of pretherapeutic gamma-glutamyltransferase on patients with nasopharyngeal carcinoma.
    Wen YF; Yang XZ; Zeng LS; Peng HH; Huang WJ; Cai LM; Zhou TC; Lin XD
    PLoS One; 2017; 12(2):e0172345. PubMed ID: 28241022
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The influence of venous tumor thrombus combined with bland thrombus on the surgical treatment and prognosis of renal cell carcinoma patients.
    Liu Z; Zhang L; Hong P; Li L; Tang S; Zhao X; Zhang Q; Zhu G; Peng R; Wang B; Chen Z; Sun Z; Yang F; Wang G; Tian X; Zhang S; Huang Y; Zhang H; Liu C; Wang S; Ma L
    Cancer Med; 2020 Aug; 9(16):5860-5868. PubMed ID: 32627973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors of Postoperative Complications in Patients Who Undergo Radical Nephrectomy and IVC Thrombectomy: A Large Contemporary Tertiary Center Analysis.
    Lue K; Russell CM; Fisher J; Kurian T; Agarwal G; Luchey A; Poch M; Pow-Sang JM; Sexton WJ; Spiess PE
    Clin Genitourin Cancer; 2016 Feb; 14(1):89-95. PubMed ID: 26453395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oncologic outcomes following surgical resection of renal cell carcinoma with inferior vena caval thrombus extending above the hepatic veins: a contemporary multicenter cohort.
    Haddad AQ; Wood CG; Abel EJ; Krabbe LM; Darwish OM; Thompson RH; Heckman JE; Merril MM; Gayed BA; Sagalowsky AI; Boorjian SA; Margulis V; Leibovich BC
    J Urol; 2014 Oct; 192(4):1050-6. PubMed ID: 24704115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of the Glasgow Prognostic Score in renal cell carcinoma: a meta-analysis.
    Shim SR; Kim SJ; Kim SI; Cho DS
    World J Urol; 2017 May; 35(5):771-780. PubMed ID: 27665441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcomes in a multi-institutional cohort of patients treated with intraoperative radiation therapy for advanced or recurrent renal cell carcinoma.
    Paly JJ; Hallemeier CL; Biggs PJ; Niemierko A; Roeder F; Martínez-Monge R; Whitson J; Calvo FA; Fastner G; Sedlmayer F; Wong WW; Ellis RJ; Haddock MG; Choo R; Shipley WU; Zietman AL; Efstathiou JA
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):618-23. PubMed ID: 24411190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project).
    Brookman-May S; May M; Shariat SF; Xylinas E; Stief C; Zigeuner R; Chromecki T; Burger M; Wieland WF; Cindolo L; Schips L; De Cobelli O; Rocco B; De Nunzio C; Feciche B; Truss M; Gilfrich C; Pahernik S; Hohenfellner M; Zastrow S; Wirth MP; Novara G; Carini M; Minervini A; Simeone C; Antonelli A; Mirone V; Longo N; Simonato A; Carmignani G; Ficarra V;
    Eur Urol; 2013 Sep; 64(3):472-7. PubMed ID: 22748912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum carbonic anhydrase 9 level is associated with postoperative recurrence of conventional renal cell cancer.
    Li G; Feng G; Gentil-Perret A; Genin C; Tostain J
    J Urol; 2008 Aug; 180(2):510-3; discussion 513-4. PubMed ID: 18550116
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of histologic subtype on cancer-specific survival in patients with renal cell carcinoma and tumor thrombus.
    Tilki D; Nguyen HG; Dall'Era MA; Bertini R; Carballido JA; Chromecki T; Ciancio G; Daneshmand S; Gontero P; Gonzalez J; Haferkamp A; Hohenfellner M; Huang WC; Koppie TM; Lorentz CA; Mandel P; Martinez-Salamanca JI; Master VA; Matloob R; McKiernan JM; Mlynarczyk CM; Montorsi F; Novara G; Pahernik S; Palou J; Pruthi RS; Ramaswamy K; Rodriguez Faba O; Russo P; Shariat SF; Spahn M; Terrone C; Vergho D; Wallen EM; Xylinas E; Zigeuner R; Libertino JA; Evans CP
    Eur Urol; 2014 Sep; 66(3):577-83. PubMed ID: 23871402
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prognostic value of venous tumor thrombus in renal cell carcinoma].
    García-Fadrique G; Budía-Alba A; Ruiz-Cerdá JL; Morales-Solchaga G; Pontones JL; Jiménez-Cruz JF
    Actas Urol Esp; 2012 Jan; 36(1):29-34. PubMed ID: 21802784
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preoperative Anemia as an Independent Prognostic Indicator of Papillary Renal Cell Carcinoma.
    Huang J; Feldman AS; Dong L; Cornejo K; Liu Q; Dahl DM; Wu S; Blute ML; Huang Y; Wu CL
    Clin Genitourin Cancer; 2015 Oct; 13(5):e353-60. PubMed ID: 25998556
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preoperative metastatic status, level of thrombus and body mass index predict overall survival in patients undergoing nephrectomy and inferior vena cava thrombectomy.
    Spiess PE; Kurian T; Lin HY; Rawal B; Kim T; Sexton WJ; Pow-Sang JM
    BJU Int; 2012 Dec; 110(11 Pt B):E470-4. PubMed ID: 22519938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of Microvascular Invasion and Tumor Necrosis on the Prognosis of Korean Patients with pT1b Renal Cell Carcinoma.
    Kwon SY; Lee JN; Kim BS; Ko YH; Song PH; Kim HT; Kim TH; Yoo ES; Choi GS; Kim BW; Kwon TG
    Urol Int; 2015; 95(1):65-71. PubMed ID: 25413438
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum Exosomal Gamma-Glutamyltransferase Activity Increased in Patients with Renal Cell Carcinoma with Advanced Clinicopathological Features.
    Horie K; Kawakami K; Fujita Y; Matsuda Y; Arai T; Suzui N; Miyazaki T; Koie T; Mizutani K; Ito M
    Oncology; 2020; 98(10):734-742. PubMed ID: 32726790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.